Piper Sandler initiated Q2 Holdings at Overweight, stating that the software banking solutions company is a top idea. The firm highlighted that Q2’s core-agnostic architecture, platform breadth, improving margins, debt-free balance sheet, and free cash flow conversion support the clearest path to durable growth.

Bernstein initiated Shopify at Outperform, noting the company is well positioned for AI. The firm stated, “Shopify, a commerce-enablement platform, sits at the center of tech’s Venn Diagram spanning eCommerce, software and payments.”

RBC initiated Dell at Outperform with a $640 price target, citing expectations of strong AI infrastructure demand.

UBS initiated Korsana Biosciences at Buy with a $55 price target, stating that the biotech company has plenty of upside.

Rothschild & Co Redburn reiterated Nvidia at Buy, expressing increased bullishness on the company’s acquisition of Hugging Face. The firm noted, “By acquiring Hugging Face, Nvidia will increase its influence in the open-model distribution layer.”

JPMorgan initiated Old National Bancorp at Overweight with a $32 December 2027 price target, stating that the regional bank possesses best-in-class return metrics.

KeyBanc initiated Linde at Overweight with a $542 price target. While acknowledging the stock is not cheap, the firm called it the “highest quality company.”

Raymond James initiated Rocket Lab at Outperform with an $80 target price, stating that shares of the emerging vertically integrated space platform are compelling.

Evercore ISI reiterated SpaceX at Outperform, noting they walk away incrementally more bullish on the visibility and monetization of the AI infrastructure opportunity, while also seeing a more aggressive competitive posture emerging in Mobile.

DA Davidson reiterated Palantir at Buy, raising the price target to $250 from $200. The firm noted, “Palantir’s AIPCon11 was focused on AI sovereignty and its approach appears to be embraced by customers. We see an increasingly long runway for PLTR.”

JPMorgan initiated Dianthus Therapeutics at Buy with a December 2027 price target of $135, stating the biotech company has plenty more room to run.

Mizuho initiated Chesapeake Utilities at Outperform with a $150 price target, citing the utility company’s “differentiated” offering.

Bank of America reiterated Oracle at Buy, stating that the company’s bullish view is based on accelerating demand in the Oracle Cloud Infrastructure segment following Thursday’s earnings report.

Bank of America upgraded International Paper to Buy from Neutral, advising investors to buy the dip in the paper company. The firm raised containerboard price forecasts along with other grades, which is the primary driver of the forecast and rating change.

Morgan Stanley reiterated Tesla at Equal Weight, raising the bull case by $20 to $840. The firm highlighted the promise of autonomous trucking software, which offers 2.3x better utilization, 20% lower cost per mile, and 6x higher profit per truck versus human driving. The firm noted, “Tesla Semi is small today but a $0.85-$1/mile FSD fee (~$12-$18k/truck/month) means small volumes can move numbers.”

Source link

Exit mobile version